238 related articles for article (PubMed ID: 22804248)
21. In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.
Yang W; Zhao J; Wang Y; Xu H; Wu Z; Hu Y; Jiang K; Shen P; Ma C; Guan Z; Zhang Y; Ma J; Shang N; Yan G; Wang Z; Dai G
Toxicol Appl Pharmacol; 2017 Jul; 327():1-12. PubMed ID: 28438631
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
23. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
24. Andrographolide inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cell line C666-1 through LKB1-AMPK-dependent signaling pathways.
Wu B; Chen X; Zhou Y; Hu P; Wu D; Zheng G; Cai Y
Pharmazie; 2018 Oct; 73(10):594-597. PubMed ID: 30223924
[TBL] [Abstract][Full Text] [Related]
25. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
26. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
[TBL] [Abstract][Full Text] [Related]
27. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
28. Critical roles of cellular glutathione homeostasis and jnk activation in andrographolide-mediated apoptotic cell death in human hepatoma cells.
Ji L; Shen K; Jiang P; Morahan G; Wang Z
Mol Carcinog; 2011 Aug; 50(8):580-91. PubMed ID: 21319226
[TBL] [Abstract][Full Text] [Related]
29. Phytochemicals from Ajwa dates pulp extract induce apoptosis in human triple-negative breast cancer by inhibiting AKT/mTOR pathway and modulating Bcl-2 family proteins.
Khan MA; Siddiqui S; Ahmad I; Singh R; Mishra DP; Srivastava AN; Ahmad R
Sci Rep; 2021 May; 11(1):10322. PubMed ID: 33990623
[TBL] [Abstract][Full Text] [Related]
30. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells.
Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH
Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392
[TBL] [Abstract][Full Text] [Related]
31. DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment.
He J; Wei X; Li S; Quan X; Li R; Du H; Yuan S; Sun L
Phytomedicine; 2019 Jun; 59():152778. PubMed ID: 31005809
[TBL] [Abstract][Full Text] [Related]
32. Andrographis paniculata extracts and major constituent diterpenoids inhibit growth of intrahepatic cholangiocarcinoma cells by inducing cell cycle arrest and apoptosis.
Suriyo T; Pholphana N; Rangkadilok N; Thiantanawat A; Watcharasit P; Satayavivad J
Planta Med; 2014 May; 80(7):533-43. PubMed ID: 24782229
[TBL] [Abstract][Full Text] [Related]
33. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
36. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.
Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W
Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263
[TBL] [Abstract][Full Text] [Related]
37. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
38. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
[TBL] [Abstract][Full Text] [Related]
39. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
40. Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF- κ B and PI3K/AKT Signaling In Vitro and In Vivo.
Xuan L; Hu JH; Bi R; Liu SQ; Wang CX
Chin J Integr Med; 2022 Apr; 28(4):349-356. PubMed ID: 35048242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
